A urinary biomarker‐based risk score correlates with multiparametric MRI for prostate cancer detection

Background Prostate cancer (PCa) diagnostics would greatly benefit from more accurate, non‐invasive techniques for the detection of clinically significant disease, leading to a reduction of over‐diagnosis and over‐treatment. The aim of this study was to determine the association between a novel urinary biomarker‐based risk score (SelectMDx), multiparametric MRI (mpMRI) outcomes, and biopsy results for PCa detection. Methods This retrospective...